Loading...
Header Logo
Keywords
Last Name
Institution

ANNA YEMELYANOVA

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S114-S122. PMID: 29521846.
      View in: PubMed
    2. Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, Bell D, Routbort M, Hudgens CW, Ivan D, Kim TB, Chen K, Eterovic AK, Shaw K, Prieto VG, Yemelyanova A, Esmaeli B. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clin Cancer Res. 2019 Feb 15; 25(4):1280-1290. PMID: 30420449.
      View in: PubMed
    3. Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, Frumovitz M, Jazaeri AA. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018; 9:2102. PMID: 30283446.
      View in: PubMed
    4. Chen H, Luthra R, Patel KP, Routbort M, Rashid A, Roy-Chowdhuri S, Lazar A, Broaddus R, Manekia J, Singh RR, Yemelyanova A. Challenges in next generation sequencing analysis of somatic mutations in transplant patients. Cancer Genet. 2018 10; 226-227:17-22. PMID: 30005850.
      View in: PubMed
    5. Jiang RT, Yemelyanova A, Xing D, Anchoori RK, Hamazaki J, Murata S, Seidman JD, Wang TL, Roden RBS. Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma. J Ovarian Res. 2017 Aug 07; 10(1):53. PMID: 28784174.
      View in: PubMed
    6. Sangoi AR, Kshirsagar M, Roma AA, Horvai AE, Chivukula M, Ellenson LH, Fadare O, Folkins AK, Garg K, Hanley K, Longacre TA, Haas J, McCluggage WG, McKenney JK, Nucci MR, Oliva E, Park KJ, Parkash V, Quick CM, Rabban JT, Rutgers JKL, Soslow R, Vang R, Yemelyanova A, Zaloudek C, Beck AH. Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas. Int J Gynecol Pathol. 2017 Jul; 36(4):386-392. PMID: 28221217.
      View in: PubMed
    7. Ring KL, Yemelyanova AV, Soliman PT, Frumovitz MM, Jazaeri AA. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468. PMID: 28233576.
      View in: PubMed
    8. Seidman JD, Krishnan J, Yemelyanova A, Vang R. Incidental Serous Tubal Intraepithelial Carcinoma and Non-Neoplastic Conditions of the Fallopian Tubes in Grossly Normal Adnexa: A Clinicopathologic Study of 388 Completely Embedded Cases. Int J Gynecol Pathol. 2016 Sep; 35(5):423-9. PMID: 26630221.
      View in: PubMed
    9. Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian XW, Yang W, Zhang J, Yemelyanova A, Malpica A, Zhang Z, Fuller GN, Liu J. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56. PMID: 26990854.
      View in: PubMed
    10. Seidman JD, Vang R, Ronnett BM, Yemelyanova A, Cosin JA. Distribution and case-fatality ratios by cell-type for ovarian carcinomas: a 22-year series of 562 patients with uniform current histological classification. Gynecol Oncol. 2015 Feb; 136(2):336-40. PMID: 25528497.
      View in: PubMed
    11. Bashir S, Jiang G, Joshi A, Miller C, Matrai C, Yemelyanova A, Caputo TA, Holcomb KM, Ellenson LH, Gupta D. Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors. Int J Gynecol Cancer. 2014 Sep; 24(7):1262-7. PMID: 25078343.
      View in: PubMed
    12. Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014 Sep; 33(5):492-9. PMID: 25083965.
      View in: PubMed
    13. Holmes BJ, Gown AM, Vang R, Ronnett BM, Yemelyanova A. PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma). Int J Gynecol Pathol. 2014 Jul; 33(4):425-31. PMID: 24901404.
      View in: PubMed
    14. Bishop JA, Yonescu R, Batista D, Yemelyanova A, Ha PK, Westra WH. Mucoepidermoid carcinoma does not harbor transcriptionally active high risk human papillomavirus even in the absence of the MAML2 translocation. Head Neck Pathol. 2014; 8(3):298-302. PMID: 24706055.
      View in: PubMed
    15. Elwood H, Kim J, Yemelyanova A, Ronnett BM, Taube JM. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression. Am J Surg Pathol. 2014 Apr; 38(4):542-7. PMID: 24625418.
      View in: PubMed
    16. Bagby C, Ronnett BM, Yemelyanova A, Maleki Z, Kuhn E, Vang R. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin. Int J Gynecol Pathol. 2013 Sep; 32(5):433-43. PMID: 23896706.
      View in: PubMed
    17. Maniar KP, Ronnett BM, Vang R, Yemelyanova A. Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients. Am J Surg Pathol. 2013 Jan; 37(1):53-60. PMID: 23026935.
      View in: PubMed
    18. Gupta M, Vang R, Yemelyanova AV, Kurman RJ, Li FR, Maambo EC, Murphy KM, DeScipio C, Thompson CB, Ronnett BM. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol. 2012 Dec; 36(12):1747-60. PMID: 22992698.
      View in: PubMed
    19. Zaino RJ, Abendroth C, Yemelyanova A, Oliva E, Lim D, Soslow R, DeLair D, Hagemann IS, Montone K, Zhu J. Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible. Gynecol Oncol. 2013 Jan; 128(1):83-87. PMID: 23063759.
      View in: PubMed
    20. Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Mod Pathol. 2013 Feb; 26(2):268-74. PMID: 22996373.
      View in: PubMed
    21. Vang R, Visvanathan K, Gross A, Maambo E, Gupta M, Kuhn E, Li RF, Ronnett BM, Seidman JD, Yemelyanova A, Shih IeM, Shaw PA, Soslow RA, Kurman RJ. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2012 May; 31(3):243-53. PMID: 22498942.
      View in: PubMed
    22. Vang R, Gupta M, Wu LS, Yemelyanova AV, Kurman RJ, Murphy KM, Descipio C, Ronnett BM. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol. 2012 Mar; 36(3):443-53. PMID: 22245958.
      View in: PubMed
    23. Seidman JD, Yemelyanova A, Cosin JA, Smith A, Kurman RJ. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review. Int J Gynecol Cancer. 2012 Mar; 22(3):367-71. PMID: 22237384.
      View in: PubMed
    24. Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer. 2012 Feb; 22(2):273-9. PMID: 22146771.
      View in: PubMed
    25. Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IeM, Kurman RJ. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011 Sep; 24(9):1248-53. PMID: 21552211.
      View in: PubMed
    26. Meriden Z, Yemelyanova AV, Vang R, Ronnett BM. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Am J Surg Pathol. 2011 Feb; 35(2):276-88. PMID: 21263249.
      View in: PubMed
    27. Seidman JD, Yemelyanova A, Zaino RJ, Kurman RJ. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol. 2011 Jan; 30(1):4-11. PMID: 21131840.
      View in: PubMed
    28. Kwak K, Yemelyanova A, Roden RB. Prevention of cancer by prophylactic human papillomavirus vaccines. Curr Opin Immunol. 2011 Apr; 23(2):244-51. PMID: 21185706.
      View in: PubMed
    29. Seidman JD, Zhao P, Yemelyanova A. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol. 2011 Mar; 120(3):470-3. PMID: 21159368.
      View in: PubMed
    30. Seidman JD, Cosin JA, Wang BG, Alsop S, Yemelyanova A, Fields A, Boice CR, Zaino RJ. Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II. Gynecol Oncol. 2010 Nov; 119(2):250-4. PMID: 20673974.
      View in: PubMed
    31. Seidman JD, Yemelyanova AV, Khedmati F, Bidus MA, Dainty L, Boice CR, Cosin JA. Prognostic factors for stage I ovarian carcinoma. Int J Gynecol Pathol. 2010 Jan; 29(1):1-7. PMID: 19952945.
      View in: PubMed
    32. Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Am J Surg Pathol. 2009 Oct; 33(10):1504-14. PMID: 19623034.
      View in: PubMed
    33. Ayhan A, Kurman RJ, Yemelyanova A, Vang R, Logani S, Seidman JD, Shih IeM. Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis. Am J Surg Pathol. 2009 Aug; 33(8):1220-4. PMID: 19461510.
      View in: PubMed
    34. Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol. 2009 Jun; 33(6):914-24. PMID: 19295407.
      View in: PubMed
    35. Posy HE, Elkas JC, Yemelyanova AV, Diaz-Montes TP, Bristow RE, Giuntoli RL. Metastatic leiomyosarcoma diagnosed after uterine artery embolization. Eur J Gynaecol Oncol. 2009; 30(2):199-202. PMID: 19480255.
      View in: PubMed
    36. Lin Z, Yemelyanova AV, Gambhira R, Jagu S, Meyers C, Kirnbauer R, Ronnett BM, Gravitt PE, Roden RB. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol. 2009 Jan; 174(1):136-43. PMID: 19095951.
      View in: PubMed
    37. Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, Kurman RJ. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol. 2008 Dec; 32(12):1835-53. PMID: 18813124.
      View in: PubMed
    38. Yemelyanova A, Mao TL, Nakayama N, Shih IeM, Kurman RJ. Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion. Am J Surg Pathol. 2008 Dec; 32(12):1800-6. PMID: 18779727.
      View in: PubMed
    39. Judson K, McCormick C, Vang R, Yemelyanova AV, Wu LS, Bristow RE, Ronnett BM. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement. Int J Gynecol Pathol. 2008 Apr; 27(2):182-90. PMID: 18317225.
      View in: PubMed
    40. Yemelyanova AV, Vang R, Judson K, Wu LS, Ronnett BM. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008 Jan; 32(1):128-38. PMID: 18162780.
      View in: PubMed
    41. Hristov AC, Young RH, Vang R, Yemelyanova AV, Seidman JD, Ronnett BM. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Am J Surg Pathol. 2007 Oct; 31(10):1502-11. PMID: 17895750.
      View in: PubMed
    42. Yemelyanova AV, Cosin JA, Bidus MA, Boice CR, Seidman JD. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008 May-Jun; 18(3):465-9. PMID: 17868343.
      View in: PubMed
    43. Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 2007 May; 31(5):653-63. PMID: 17460447.
      View in: PubMed
    44. Vang R, Gown AM, Wu LS, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006 Nov; 19(11):1421-8. PMID: 16980943.
      View in: PubMed
    45. Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006 Sep; 30(9):1130-9. PMID: 16931958.
      View in: PubMed
    46. Seidman JD, Horkayne-Szakaly I, Cosin JA, Ryu HS, Haiba M, Boice CR, Yemelyanova AV. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Gynecol Oncol. 2006 Nov; 103(2):703-8. PMID: 16828848.
      View in: PubMed
    47. Yemelyanova AV, Winter W, Seidman JD. Venous thrombosis in the broad ligament: is it a predictor of postoperative pulmonary embolism in gynecological cancer patients? A case-control study. Int J Gynecol Pathol. 2004 Apr; 23(2):176-9. PMID: 15084847.
      View in: PubMed
    48. Incidental Serous Tubal Intraepithelial Carcinoma and Non-Neoplastic Conditions of the Fallopian Tubes in Grossly Normal Adnexa. International Journal of Gynecological Pathology.
    49. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum. American Journal of Surgical Pathology.
    YEMELYANOVA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description